Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page
- CheckyesterdayChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedUpdated study status and revised contacts/locations, reflecting current trial progress.SummaryDifference0.0%

- Check37 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the history. The funding/operational-status notice and the earlier Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check44 days agoChange DetectedAdded a government funding status notice and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedThe history page now shows a glossary option, green highlights for additions and red highlights for deletions, and a revised 'Revision' banner to indicate version changes; these changes are cosmetic and do not affect the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.